Valeant pharmaceuticals documentary

But Pearson, who took. . . Sep 1, 2018 · Under Pearson’s leadership, Valeant Pharmaceuticals slashed its research budget and focused entirely on buying up other companies’ medicines and then jacking up the prices. Aug 26, 2016 · Actavis ultimately thwarted Valeant, and purchased Allergan last year in a deal valued at $66 billion. Between July 2015 and March 2016 Valeant plunged from $257 to $28 – losing 90% of its value – making it the biggest profit maker for the company in 2016. A young pharmaceutical company CEO, named Martin Shkreli, raises the price of a drug for a rare disease and becomes the "most hated man in America". .